
### [NCIT:C3867](http://purl.obolibrary.org/obo/NCIT_C3867)
**Label:** Fallopian Tube Carcinoma

**Subclasses:** [NCIT:C115429](http://purl.obolibrary.org/obo/NCIT_C115429) (Recurrent Fallopian Tube Carcinoma), [NCIT:C6265](http://purl.obolibrary.org/obo/NCIT_C6265) (Fallopian Tube Adenocarcinoma), [NCIT:C6279](http://purl.obolibrary.org/obo/NCIT_C6279) (Fallopian Tube Endometrioid Adenocarcinoma), [NCIT:C6278](http://purl.obolibrary.org/obo/NCIT_C6278) (Fallopian Tube Gestational Choriocarcinoma), [NCIT:C6267](http://purl.obolibrary.org/obo/NCIT_C6267) (Fallopian Tube Papillary Adenocarcinoma), [NCIT:C40104](http://purl.obolibrary.org/obo/NCIT_C40104) (Fallopian Tube Transitional Cell Carcinoma), [NCIT:C40105](http://purl.obolibrary.org/obo/NCIT_C40105) (Stage 0 Fallopian Tube Cancer), [NCIT:C6280](http://purl.obolibrary.org/obo/NCIT_C6280) (Fallopian Tube Clear Cell Adenocarcinoma), [NCIT:C126449](http://purl.obolibrary.org/obo/NCIT_C126449) (Serous Tubal Intraepithelial Carcinoma), [NCIT:C40103](http://purl.obolibrary.org/obo/NCIT_C40103) (Fallopian Tube Mucinous Adenocarcinoma), [NCIT:C40455](http://purl.obolibrary.org/obo/NCIT_C40455) (Hereditary Fallopian Tube Carcinoma), [NCIT:C6282](http://purl.obolibrary.org/obo/NCIT_C6282) (Fallopian Tube Squamous Cell Carcinoma), [NCIT:C6281](http://purl.obolibrary.org/obo/NCIT_C6281) (Undifferentiated Fallopian Tube Carcinoma), [NCIT:C126456](http://purl.obolibrary.org/obo/NCIT_C126456) (High Grade Fallopian Tube Serous Adenocarcinoma), [NCIT:C40099](http://purl.obolibrary.org/obo/NCIT_C40099) (Fallopian Tube Serous Adenocarcinoma), [NCIT:C126457](http://purl.obolibrary.org/obo/NCIT_C126457) (Low Grade Fallopian Tube Serous Adenocarcinoma), 

**Class expressions from DL-Learner:**

- Thing 52.66%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 39.90%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40395](http://purl.obolibrary.org/obo/NCIT_C40395) (Malignant Breast Myoepithelioma))) 39.90%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40388](http://purl.obolibrary.org/obo/NCIT_C40388) (Periductal Breast Myoepitheliosis))) 39.90%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40384](http://purl.obolibrary.org/obo/NCIT_C40384) (Breast Ductal Adenoma))) 39.90%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40383](http://purl.obolibrary.org/obo/NCIT_C40383) (Breast Apocrine Adenoma))) 39.90%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40379](http://purl.obolibrary.org/obo/NCIT_C40379) (Angiosarcoma of the Skin of the Arm after Radical Mastectomy followed by Lymphedema))) 39.90%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40378](http://purl.obolibrary.org/obo/NCIT_C40378) (Post-Radiotherapy Breast Angiosarcoma))) 39.90%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40377](http://purl.obolibrary.org/obo/NCIT_C40377) (Breast Follicular Lymphoma))) 39.90%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40376](http://purl.obolibrary.org/obo/NCIT_C40376) (Breast Burkitt Lymphoma))) 39.90%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40375](http://purl.obolibrary.org/obo/NCIT_C40375) (Breast Diffuse Large B-Cell Lymphoma))) 39.90%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C4037](http://purl.obolibrary.org/obo/NCIT_C4037) (Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome))) 39.90%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40369](http://purl.obolibrary.org/obo/NCIT_C40369) (Sebaceous Breast Carcinoma))) 39.90%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40367](http://purl.obolibrary.org/obo/NCIT_C40367) (Acinic Cell Breast Carcinoma))) 39.90%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40366](http://purl.obolibrary.org/obo/NCIT_C40366) (Oncocytic Breast Carcinoma))) 39.90%


